Indications and uses
relieves occasional constipation (irregularity) generally produces bowel movement in 6-12 hours
relieves occasional constipation (irregularity) generally produces bowel movement in 6-12 hours
take preferably at bedtime or as directed by a doctor age starting dosage maximum dosage adults and children 12 years and over 2 tablets once a day 4 tablets twice a day children 6 to under 12 years 1 tablet once a day 2 tablets twice a day children 2 to under 6 years 1/2 tablet once a day 1 tablet twice a day children under 2 years ask a doctor ask a doctor
Active ingredient (in each tablet)
Sennosides 8.6 mg
Purpose
Laxative
Do not use
Ask a doctor before use if you have
Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away.
| age | starting dosage | maximum dosage |
adults and children 12 years and over | 2 tablets once a day | 4 tablets twice a day |
children 6 to under 12 years | 1 tablet once a day | 2 tablets twice a day |
children 2 to under 6 years | 1/2 tablet once a day | 1 tablet twice a day |
children under 2 years | ask a doctor | ask a doctor |
croscarmellose sodium, dicalcium phosphate, hypromellose, magnesium stearate, maltodextrin, microcrystalline cellulose, mineral oil, polyethylene glycol and talc
1-800-645-2158
*Rugby Laboratories is not affiliated with the owner of the registered trademark Senokot®.
SAVE CARTON FOR COMPLETE DRUG FACTS
TAMPER EVIDENT: DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING
Distributed by: Rugby Laboratories
17177 N Laurel Park Dr., Suite 233,
Livonia, MI 48152
Rugby ®
NDC 0536-1168-10
COMPARE TO THE ACTIVE INGREDIENT IN SENOKOT®*
Standardized Senna Concentrate
Sennosides 8.6 mg
SENEXON ®
Natural Vegetable Stimulant Ingredient
Laxative
1000 Tablets
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 0536-1168 | 0536-1168-10, 0536-1168-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SENNOSIDES | 3FYP5M0IJX | ACTIB |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| MALTODEXTRIN | 7CVR7L4A2D | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| LIGHT MINERAL OIL | N6K5787QVP | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE | O7TSZ97GEP | IACT |
| HYPROMELLOSES | 3NXW29V3WO | IACT |
| POLYETHYLENE GLYCOL 400 | B697894SGQ | IACT |
| TALC | 7SEV7J4R1U | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 0eafc535-7f23-7eab-e063-6294a90a07c8 | 78fc2b97-ea53-0538-e053-2991aa0a9099 | 2024-01-11 | Warnings | 0eafc535-7f23-7eab-e063-6294a90a07c8 78fc2b97-ea53-0538-e053-2991aa0a9099 |
Adverse event summaries are temporarily unavailable. Other product information remains available.